• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Report: US pressuring India to halt price caps, allow market withdrawals

Report: US pressuring India to halt price caps, allow market withdrawals

October 5, 2017 By Fink Densford

India's National Pharmaceutical Pricing Authority

The US government is pressuring India to halt the extension of price caps on medical devices and to allow businesses to withdraw their products from the market if they don’t want to sell at those rates, according to a report from The Hindu.

The push came from a senior US Trade Representative, according to the report, after the country has taken steps to limit the prices on stents, orthopedic knee implant devices and is considering further caps for other medical devices.

“It is a principal concern for the United States,” the anonymous representative said, according to the report.

India’s trade ministry has not yet responded with an official comment, The Hindu reports, but Prime Minister Narendra Modi has stated that providing affordable healthcare to patients takes precedence over corporate interests.

India’s government has equated high margins on medical devices with “illegal profiteering,” claiming that the margins can exceed 400%.

“Indian government should retain a pro-public health stance on pricing medical devices to ensure access to affordable healthcare,” New Delhi-based Observer Research Foundation associate fellow Tanoubi Ngangom said, according to The Hindu.

The US has applied pressure to India to consider removing the caps in the past, according to the report. In May, a group of US Congress members urged them to reconsider stent caps.

Late last month, India’s NPPA told Boston Scientific (NYSE:BSX) it has to choose between either seeking to withdraw its premium coronary stents from the market or seeking a higher price for them after the Authority received applications for both options.

Earlier in September, the NPPA said it won’t be revising its cap on coronary stents, applied earlier this year, until Feb. 2018.

Filed Under: Business/Financial News, Orthopedics, Regulatory/Compliance, Stents Tagged With: India, Indian National Pharmaceutical Pricing Authority (NPPA)

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy